518.54

0.28% -1.46

After Hours: 518.54

Medpace Holdings Inc (MEDP)

Overview News Price History Option Chain Financials Discussions Forecast

Medpace Holdings Inc stock is traded at $518.54, with a volume of 545.65K. It is down -0.28% in the last 24 hours and up +15.13% over the past month. Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Previous Close:

$520.00

Open:

$527.97

24h Volume:

545.65K

Relative Volume:

1.57

Market Cap:

$14.81B

Revenue:

$2.53B

Net Income/Loss:

$451.12M

P/E Ratio:

33.91

EPS:

15.2927

Net Cash Flow:

$681.87M

1W Performance:

-0.41%

1M Performance:

+15.13%

6M Performance:

+0.82%

1Y Performance:

+70.01%

1-Day Range:

$515.90

$529.26

1-Week Range:

$487.86

$529.26

52-Week Range:

$250.05

$628.92

Medpace Holdings Inc Stock (MEDP) Company Profile

Name

Medpace Holdings Inc

Sector

Healthcare (1112)

Industry

Diagnostics & Research (52)

Phone

(513) 579-9911

Address

5375 MEDPACE WAY, CINCINNATI, OH

Employee

6,200

Twitter

@WorkatMedpace

Next Earnings Date

2026-04-22

Latest SEC Filings

MEDP's Discussions on Twitter

Compare MEDP vs TMO, DHR, IDXX, A, WAT

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MEDP Medpace Holdings Inc	518.54	14.85B	2.53B	451.12M	681.87M	15.29
TMO Thermo Fisher Scientific Inc	531.67	195.93B	44.56B	6.72B	6.29B	17.74
DHR Danaher Corp	198.14	140.56B	24.57B	3.60B	5.26B	5.051
IDXX Idexx Laboratories Inc	580.76	46.39B	4.30B	1.06B	1.04B	13.08
A Agilent Technologies Inc	119.77	34.02B	7.07B	1.29B	993.00M	4.5355
WAT Waters Corp	326.20	32.49B	3.17B	642.63M	516.49M	10.77

Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-06-26	Upgrade	Barclays	Underweight → Equal Weight
Mar-03-26	Initiated	RBC Capital Mkts	Outperform
Feb-18-26	Upgrade	TD Cowen	Sell → Hold
Feb-13-26	Upgrade	Jefferies	Hold → Buy
Feb-10-26	Upgrade	Robert W. Baird	Neutral → Outperform
Nov-13-25	Initiated	BMO Capital Markets	Market Perform
Oct-02-25	Downgrade	Barclays	Equal Weight → Underweight
Sep-03-25	Downgrade	Rothschild & Co Redburn	Buy → Neutral
Jul-29-25	Downgrade	UBS	Neutral → Sell
Jul-23-25	Downgrade	TD Cowen	Hold → Sell
Jun-24-25	Initiated	Barclays	Equal Weight
Apr-22-25	Downgrade	William Blair	Outperform → Mkt Perform
Apr-14-25	Downgrade	TD Cowen	Buy → Hold
Mar-24-25	Initiated	Leerink Partners	Market Perform
Oct-23-24	Downgrade	Robert W. Baird	Outperform → Neutral
Oct-14-24	Initiated	Redburn Atlantic	Buy
Sep-27-24	Downgrade	UBS	Buy → Neutral
Sep-25-24	Downgrade	Jefferies	Buy → Hold
Aug-01-24	Initiated	Truist	Hold
May-29-24	Initiated	TD Cowen	Buy
May-28-24	Initiated	Mizuho	Buy
Apr-23-24	Upgrade	Jefferies	Hold → Buy
Mar-18-24	Initiated	Deutsche Bank	Hold
Feb-15-24	Upgrade	UBS	Neutral → Buy
Oct-24-23	Upgrade	Robert W. Baird	Neutral → Outperform
May-08-23	Upgrade	Guggenheim	Neutral → Buy
Oct-27-22	Upgrade	UBS	Sell → Neutral
Sep-07-22	Initiated	UBS	Sell
May-24-22	Initiated	Guggenheim	Neutral
Aug-05-21	Resumed	Credit Suisse	Outperform
Oct-02-20	Upgrade	Truist	Hold → Buy
Jun-08-20	Upgrade	Robert W. Baird	Underperform → Neutral
May-13-20	Downgrade	Wolfe Research	Outperform → Peer Perform
Apr-30-20	Upgrade	SunTrust	Sell → Hold
Apr-20-20	Downgrade	Robert W. Baird	Neutral → Underperform
Mar-17-20	Downgrade	SunTrust	Hold → Sell
Jan-27-20	Downgrade	SunTrust	Buy → Hold
Oct-31-18	Upgrade	SunTrust	Hold → Buy
Sep-17-18	Initiated	SunTrust	Hold
Jul-31-18	Upgrade	William Blair	Mkt Perform → Outperform
Nov-01-17	Downgrade	William Blair	Outperform → Mkt Perform
Sep-29-17	Initiated	Raymond James	Mkt Perform
Jul-10-17	Downgrade	KeyBanc Capital Mkts	Overweight → Sector Weight

View All

Medpace Holdings Inc Stock (MEDP) Latest News

12:38 PM

Deadline Alert: Medpace Holdings, Inc. (MEDP) Shareholders - GlobeNewswire

12:38 PM

11:04 AM

MEDP INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Medpace Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

11:04 AM

09:00 AM

MEDP Investor Alert: Medpace Holdings Inc. Securities Fraud LawsuitInvestors With Losses May Seek to Lead the Class Action After Company Allegedly Concealed Backlog Deterioration: Levi & Korsinsky - PR Newswire

09:00 AM

04:02 AM

Medpace Holdings Inc stock (US5840631062): Is its CRO execution strong enough to unlock new upside? - AD HOC NEWS

04:02 AM

Apr 14, 2026

Investors Urged to Contact Robbins LLP Over Medpace Holdings Losses - National Today

Apr 14, 2026

A Look at Medpace Holdings Inc (MEDP) After 3.8% Gain -- GF Value $472.51 vs Price $520.00 - GuruFocus

Apr 14, 2026

Did You Lose Money Investing in Medpace Holdings Inc.? - GlobeNewswire

Apr 14, 2026

Did You Lose Money Investing in Medpace Holdings Inc.? Robbins LLP Urges Investors with Significant Losses to Contact the Firm for Information About Their Rights Against MEDP - GlobeNewswire Inc.

Apr 14, 2026

Bronstein, Gewirtz & Grossman LLC Urges Medpace Holdings, - GlobeNewswire

Apr 14, 2026

MEDP INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Medpace Holdings, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 14, 2026

Lead Plaintiff Deadline of June 8, 2026 in Shareholder - GlobeNewswire

Apr 14, 2026

Medpace Holdings Sued for Securities Law Violations - National Today

Apr 14, 2026

MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Morningstar

Apr 14, 2026

Apr 13, 2026

Why Medpace (MEDP) Outpaced the Stock Market Today - Yahoo Finance

Apr 13, 2026

Shareholders of Medpace Holdings, Inc. Should Contact Levi & Korsinsky Before June 8, 2026 ... - Bluefield Daily Telegraph

Apr 13, 2026

Shareholders of Medpace Holdings, Inc. Should Contact Levi - GlobeNewswire

Apr 13, 2026

FinancialContentDeadline Approaching: Medpace Holdings, Inc. (MEDP) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith - FinancialContent

Apr 13, 2026

MEDP SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Medpace Holdings, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 13, 2026

Pomerantz LLP Alerts Shareholders to Investor Suit Against Medpace Holdings, Inc. – MEDP - ACCESS Newswire

Apr 13, 2026

Apr 12, 2026

MEDP SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Medpace Holdings, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 12, 2026

Apr 11, 2026

Medpace Investors Opportunity to Lead Lawsuit - National Today

Apr 11, 2026

MEDP INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Action Lawsuit - The Daily Tribune News

Apr 11, 2026

Assessing Medpace Holdings (MEDP) Valuation After Recent Share Price Weakness - Yahoo Finance

Apr 11, 2026

Apr 10, 2026

Dorsey Wright & Associates's Medpace Holdings Inc(MEDP) Holding History - GuruFocus

Apr 10, 2026

MEDP Investors Have Opportunity to Lead Medpace Holdings Securities Fraud Lawsuit - National Today

Apr 10, 2026